首页> 外文OA文献 >Preliminary Results Of Phase II Trial Of Clofarabine With Parenteral Busulfan (CLO/BU) Followed By Allogeneic Related Or Unrelated Donor Transplantation For The Treatment Of Hematologic Malignancies

【2h】

Preliminary Results Of Phase II Trial Of Clofarabine With Parenteral Busulfan (CLO/BU) Followed By Allogeneic Related Or Unrelated Donor Transplantation For The Treatment Of Hematologic Malignancies

机译：氯法拉滨与肠外白消安（CLO / BU）联合异基因相关或不相关供体移植治疗血液系统恶性肿瘤的第二期氯法拉滨试验的初步结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Agura E.; Berryman R.B; Luis P.; Estil V.; Tadic-Ovcina M.; Woelfel R.; Fay J.;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Romidepsin (Rom) in Combination with Fludarabine (Flu) and Busulfan (Bu) Conditioning Followed by Rom Maintenance in Patients with T-Cell Malignancies Receiving Allogeneic Stem Cell Transplant (Allo-SCT): Early Results of a Phase I/II Trial [J] . Jonathan E. Brammer, Ben C. Valdez, Richard E. Champlin, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2018,第3期

机译：Romidepsin（ROM）与Fludarabine（Flu）和Busulfan（Bu）调节组合，然后在接受同种异体干细胞移植（Allo-SCT）的T细胞恶性肿瘤患者中进行ROM维护：I / II期试验的早期结果
2. Romidepsin (Rom) in Combination with Fludarabine (Flu) and Busulfan (Bu) Conditioning Followed by Rom Maintenance in Patients with T-Cell Malignancies Receiving Allogeneic Stem Cell Transplant (Allo-SCT): Early Results of a Phase I/II Trial [J] . Jonathan E. Brammer, Ben C. Valdez, Richard E. Champlin, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2018,第3期

机译：Romidepsin（ROM）与Fludarabine（Flu）和Busulfan（Bu）调节组合，然后在接受同种异体干细胞移植（Allo-SCT）的T细胞恶性肿瘤患者中进行ROM维护：I / II期试验的早期结果
3. Busulfan (Bu) in Combination with Double Nucleoside Analogues Fludarabine (Flu) and Clofarabine (Clo) Plus Vorinostat As a Novel Reduced Toxicity Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients (pts) with Acute Leukemia [J] . Kebriaei Partow, Wei Wei, Thall Peter F., Blood: The Journal of the American Society of Hematology . 2016,第22期

机译：白消安（Bu）与双核苷类似物氟达拉滨（Flu）和氯法拉滨（Clo）加上伏立诺他合作为急性白血病患者（pts）同种异体造血细胞移植（HCT）的新型毒性降低的条件疗法
4. Intravenous Busulfan Reduces Toxicity Associated with Myeloablative Allogeneic Hematopoietic Transplantation in Patients with Myeloid Malignancies [C] . A. Shimoni, B. Bxelorai, I. Hardan, European Haematology Association . 2002

机译：静脉内的伯鲁兰减少骨髓恶性肿瘤患者患有髓鞘异产造血移植的毒性
5. Genetic Associations in Acute Leukemia Patients After Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation [D] . Rizvi, Abbas A. 2019

机译：匹配的无关供体同种异体造血干细胞移植后急性白血病患者的遗传协会。
6. PHASE II TRIAL OF GVHD PROPHYLAXIS WITH POST-TRANSPLANTATION CYCLOPHOSPHAMIDE FOLLOWING REDUCED-INTENSITY BUSULFAN/FLUDARABINE (BU/FLU) CONDITIONING FOR HEMATOLOGICAL MALIGNANCIES [O] . Amin M. Alousi, Jonathan E. Brammer, Rima M. Saliba, -1

机译：降低强度的布舒芬/氟达拉滨（BU / FLU）治疗血液学恶性肿瘤后移植后环磷酰胺对GVHD脯氨酸的II期试验
7. Preliminary Results of Phase II Trial of clofarabine With Parenteral Busulfan (CLO/BU) Followed by Allogeneic Related or Unrelated Donor Transplantation for the Treatment of Hematologic Malignancies [O] . Agura E., Berryman R.B., Pineiro L., 2011

机译：氯法拉滨Ⅱ期试验与肠外白消安（CLO / BU）联合同种异体相关或不相关供体移植治疗血液系统恶性肿瘤的初步结果

Preliminary Results Of Phase II Trial Of Clofarabine With Parenteral Busulfan (CLO/BU) Followed By Allogeneic Related Or Unrelated Donor Transplantation For The Treatment Of Hematologic Malignancies

著录项

引文网络

相似文献

相关主题

期刊订阅